Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

High-density lipoproteins (HDLs) represent a family of particle characterized by the
presence of apolipoprotein AI (apoA-I) and by their ability to transport cholesterol from …

Dyslipidemia is commonly associated with diabetes (T2DM). This has been demonstrated
for the Caucasian population, but few data are available for Asian Indians. The paper aims …

Aims/Hypothesis One of the hallmarks of diabetes is impaired endothelial function. Previous
studies showed that HDL can exert protective effects on endothelium stimulating NO …

The SGLT2 inhibitor empagliflozin reduced cardiovascular mortality by 38% and heart
failure (HF) hospitalizations by 35% in diabetic patients. We have recently demonstrated the …

Almost 600 million people are predicted to have diabetes mellitus (DM) by 2035. Diabetic
patients suffer from increased rates of microvascular and macrovascular complications …

Background Aortic calcification has been shown to share the same risk factors as
atherosclerosis which suggested a potential benefit from statins therapy. In view of the …

Purpose Dyslipidemia is claimed to be associated with an increased risk of type 2 diabetes
mellitus (T2DM). However, first-degree relatives (FDRs) of patients with T2DM are reported …

Background Carotid atherosclerosis, especially the rupture of unstable plaques, plays an
important role in the development of stroke. A novel lipid ratio, the non-high-density …

In prediabetes, blood glucose levels are higher than normal; however, they remain below
the diabetes threshold. Studies conducted on biomarkers for this disease result in controlling …